Select a community
Parkinson's
Find out more about the PatientsLikeMe
Parkinson's Community
Home > Community Treatment Reports > Carbidopa-Levodopa 25-100 (carbidopa-levodopa) Treatment Report
What is Carbidopa-Levodopa 25-100?

Levodopa 100 mg, a dopamine precursor used to treat the movement disorder symptoms of Parkinson's disease is combined with carbidopa 25 mg. Carbidopa is often included with levodopa-containing drugs in order to boost its efficacy by slowing down the metabolism of dopamine.

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
5 23%
Mild
5 23%
None
12 55%

Most commonly reported side effects

Drowsiness
7 32%
Feel drunk when I increase to new dosage
2 9%
Dizziness
2 9%
Dyskinesia
1 5%
Vivid dreams
1 5%
hallucinations
1 5%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Carbidopa-Levodopa 25-100. See all 23 dosages

  1.5 25mg-100mg as needed 25 mg-100 mg all the time (24/7) 25mg-100mg as needed 3 cap(s) daily 3 other daily 3.5 tab(s) daily 4 other daily 25 mg daily 25 mg-100 mg daily 2 x 25 mg-100 mg daily 2.5 x 25 mg-100 mg daily 3 x 10 mg-100 mg daily 3 x 25 mg-100 mg daily 4 x 10 mg-100 mg daily 4 x 25 mg-100 mg daily 4.5 x 25 mg-100 mg daily 5 x 25 mg-100 mg daily 6 x 25 mg-100 mg daily 7 x 25 mg-100 mg daily 8 x 25 mg-100 mg daily 1000 mg daily 10 x 25 mg-100 mg daily 12 x 25 mg-100 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 26 Number of Patients: 26 1 Number of Patients: 1 10 Number of Patients: 10 1 Number of Patients: 1 6 Number of Patients: 6 6 Number of Patients: 6 2 Number of Patients: 2 8 Number of Patients: 8 1 Number of Patients: 1 3 Number of Patients: 3 2 Number of Patients: 2  

Stop Reasons

Why Patients Stopped Taking Carbidopa-Levodopa 25-100 (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other
3 60% Other: 60%
Personal research
2 40% Personal research: 40%
Did not seem to work
1 20% Did not seem to work: 20%

See all 5 patients who’ve stopped taking Carbidopa-Levodopa 25-100

Currently Taking Carbidopa-Levodopa 25-100

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
4
13
15
15
20

Stopped Taking Carbidopa-Levodopa 25-100

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
2
1
0
1
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
16 73%
Usually
5 23%
Sometimes
1 5%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
3 14%
A little
5 23%
Not at all
14 64%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
3 14%
< $25
17 77%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.